Giulia Sorgentoni

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

Matteo Santoni, Sebastiano Buti, Zin Myint et al. · European Urology Oncology · 2023 · 77 citations · Full text

Medicine, Immunology, Oncology +14

<scp>TNF</scp>‐α inhibitors reduce the pathological Th₁–Th₁₇/Th₂ imbalance in cutaneous mesenchymal stem cells of psoriasis patients

Anna Campanati, Monia Orciani, Raffaella Lazzarini et al. · Experimental Dermatology · 2016 · 49 citations

Medicine, Dermatology, Immunology +17

MSCs and inflammation: new insights into the potential association between ALCL and breast implants

Monia Orciani, Giulia Sorgentoni, Matteo Torresetti et al. · Breast Cancer Research and Treatment · 2016 · 44 citations

Medicine, Immunology, Pathobiology +10

Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study

Matteo Santoni, Francesco Massari, Zin Myint et al. · Targeted Oncology · 2023 · 41 citations · Full text

Medicine, Immunology, Oncology +12

Indirect co-cultures of healthy mesenchymal stem cells restore the physiological phenotypical profile of psoriatic mesenchymal stem cells

Anna Campanati, Monia Orciani, Giulia Sorgentoni et al. · Clinical & Experimental Immunology · 2018 · 38 citations · Full text

Life Sciences, Cell Biology, Immunology +17